{"count": 1, "results": [{"_id": "27212150", "pmid": 27212150, "title": "Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons.", "journal": "Expert Opin Drug Deliv", "authors": ["Tulbah AS", "Ong HX", "Colombo P", "Young PM", "Traini D"], "date": "2016-10-01T00:00:00Z", "doi": "10.1080/17425247.2016.1193150", "meta_date_publication": "2016 Oct", "meta_volume": "13", "meta_issue": "10", "meta_pages": "1407-20", "score": 50051.43, "text_hl": "Evidence could potentially be used to support the delivery of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@ as inhaled formulation for the treatment of @DISEASE_Chronic_Disease @DISEASE_MESH:D002908 @@@chronic@@@ @<m>DISEASE_Respiratory_Tract_Diseases</m> @DISEASE_MESH:D012140 @@@respiratory diseases@@@. ", "citations": {"NLM": "Tulbah AS, Ong HX, Colombo P, Young PM, Traini D. Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons. Expert Opin Drug Deliv. 2016 Oct;13(10):1407-20. PMID: 27212150", "BibTeX": "@article{27212150, title={Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons.}, author={Tulbah AS and Ong HX and Colombo P and Young PM and Traini D}, journal={Expert Opin Drug Deliv}, volume={13}, number={10}, pages={1407-20}}"}}]}